|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400087838 |
|
最近更新日期: Date of Last Refreshed on: |
2024-08-05 17:47:44 |
|
注册时间: Date of Registration: |
2024-08-05 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
线上线下融合式病友互助对肺癌晚期患者心理痛苦影响的研究 |
|
Public title: |
Research on the influence of Online and Offline Patient Peer Support on the Psychological Distress of Patients with Advanced Lung Cancer |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
线上线下融合式病友互助对肺癌晚期患者心理痛苦影响的研究 |
|
Scientific title: |
Research on the influence of Online and Offline Patient Peer Support on the Psychological Distress of Patients with Advanced Lung Cancer |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
练素英 |
研究负责人: |
练素英 |
|
Applicant: |
Lian Suying |
Study leader: |
Lian Suying |
|
申请注册联系人电话: Applicant telephone: |
+86 181 5063 9183 |
研究负责人电话: Study leader's telephone: |
+86 181 5063 9183 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
85027650@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
85027650@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
福建省福州肺科医院 |
研究负责人通讯地址: |
福建省福州肺科医院内四区 |
|
Applicant address: |
Fuzhou Pulmonary Hospital, Fujian Province |
Study leader's address: |
Fuzhou Pulmonary Hospital in Fujian province fouth deparment |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
福建省福州肺科医院 |
||
|
Applicant's institution: |
Fuzhou Pulmonary Hospital, Fujian Province |
||
|
研究负责人所在单位: |
福建省福州肺科医院 |
||
|
Affiliation of the Leader: |
Fuzhou Pulmonary Hospital, Fujian Province |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2022-008(科研)-01 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
福建省福州结核病防治院伦理委员会 |
||
|
Name of the ethic committee: |
Fuzhou Tuberculosis Control Hospital of Fujian Province |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2022-08-11 00:00:00 |
||
|
伦理委员会联系人: |
苏林玲 |
||
|
Contact Name of the ethic committee: |
Su Linling |
||
|
伦理委员会联系地址: |
福建省福州市仓山区湖边2号 |
||
|
Contact Address of the ethic committee: |
2 Lakeside, Cangshan District, Fuzhou City, Fujian Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 591 6262 7341 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
福建省福州肺科医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Fuzhou Pulmonary Hospital, Fujian Province |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
福建省福州市仓山区湖边2号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
2 Lakeside, Cangshan District, Fuzhou City, Fujian Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
福州市科技局 |
||||||||||||||||||||||
|
Source(s) of funding: |
Fuzhou Science and Technology Bureau |
||||||||||||||||||||||
|
Target disease: |
The Psychological Distress of Patients with Advanced Lung Cancer |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
明确线下病房探访服务融合线上微信病友互助模式对减轻肺癌晚期患者心理痛苦、减少焦虑抑郁情绪等方面的干预效果 |
||||||||||||||||||||||
|
Objectives of Study: |
To clarify the intervention effect of offline ward visit service combined with online wechat patient mutual assistance mode on reducing psychological pain, anxiety and depression in advanced lung cancer patients |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
志愿者纳入标准:(1)诊断肺癌半年以上,肺癌患者已完成放化疗等主要治疗,一般情况较好;(2)年龄:≤70岁;(3)能进行日常沟通交流;(4)生活自理,行走功能正常,能完成一般体力活动;(5)会使用微信者。 患者纳入标准:(1)肺癌晚期患者,首次住院治疗;(2)自行或在研究者的帮助下能完成问卷填写;(3)与研究者沟通无障碍;(4)愿意接受本研究的病友互助服务。 |
||||||||||||||||||||||
|
Inclusion criteria |
Inclusion criteria for volunteers: (1) Diagnosed with lung cancer for more than half a year, and completed the main treatments such as radiotherapy and chemotherapy, and in a good general condition; (2) Age: ≤70 years old; (3) Able to communicate with others in daily life; (4) Self-care and normal walking function, able to complete general physical activities; (5) Able to use WeChat. Inclusion criteria for patients: (1) Patients with advanced lung cancer, undergoing hospitalization for the first time; (2) Able to complete the questionnaire independently or with the help of researchers; (3) Able to communicate with researchers without barriers; (4) Willing to accept the peer support service provided in this study. |
||||||||||||||||||||||
|
排除标准: |
志愿者排除标准:(1)不愿参加规范化志愿者培训的肺癌患者;(2)无法按时进行志愿服务者。 患者排除标准:(1)严重躯体疾病,不能配合的患者;(2)患有精神疾病、认知障碍的患者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
Exclusion criteria for volunteers: (1) Lung cancer patients who are unwilling to participate in standardized volunteer training; (2) Those who are unable to perform volunteer services on time. Exclusion criteria for patients: (1) Patients with severe physical illnesses who are unable to cooperate; (2) Patients with mental illnesses or cognitive impairments. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2022-10-01 00:00:00至 To 2024-04-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2023-03-03 00:00:00 至 To 2023-08-17 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
结束 /Completed |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
采用 SPSS 21.0软件完成随机分组,研究者先对150 名研究对象从 1~ 150 编号,在软件中生成150个随机数字,对随机数字进行排序,按排序的序号由小到大均分成A组和B组和C组各50例。将序号码装入信封内,研究对象入组后随机抽取一个信封,内的号码作为入组依据。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
SPSS 21.0 software was used to complete the random grouping. The researchers first numbered 150 subjects from 1 to 150, generated 150 random numbers in the software, sorted the random numbers, and divided them into group A, Group B and Group C with 50 cases each according to the sequence number from small to large. The sequence number was put into the envelope, and an envelope was randomly selected after the study subjects were enrolled, and the number inside was used as the basis for inclusion. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
None |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
2024.12.30前在ResMan(www.medreman.org.cn)公开原始数据 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Publish the raw data on ResMan (www.medreman.org.cn) by December 30, 2024. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
CRF |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
CRF |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |